Your browser doesn't support javascript.
loading
Weight-based enoxaparin with anti-factor Xa assay-based dose adjustment for venous thromboembolic event prophylaxis in adult trauma patients results in improved prophylactic range targeting.
Rodier, Simon Gabriel; Bukur, Marko; Moore, Samantha; Frangos, Spiros George; Tandon, Manish; DiMaggio, Charles Joseph; Ayoung-Chee, Patricia; Marshall, Gary Thomas.
Afiliación
  • Rodier SG; Department of Surgery, Bellevue Hospital Center, New York University School of Medicine, 462 First Avenue, New York, NY, 10016, USA.
  • Bukur M; Department of Surgery, Bellevue Hospital Center, New York University School of Medicine, 462 First Avenue, New York, NY, 10016, USA.
  • Moore S; Department of Surgery, Bellevue Hospital Center, New York University School of Medicine, 462 First Avenue, New York, NY, 10016, USA.
  • Frangos SG; St. John's University College of Pharmacy and Health Sciences, 8000 Utopia Parkway, Queens, NY, 11439, USA.
  • Tandon M; Department of Surgery, Bellevue Hospital Center, New York University School of Medicine, 462 First Avenue, New York, NY, 10016, USA.
  • DiMaggio CJ; Department of Surgery, Bellevue Hospital Center, New York University School of Medicine, 462 First Avenue, New York, NY, 10016, USA.
  • Ayoung-Chee P; Department of Surgery, Bellevue Hospital Center, New York University School of Medicine, 462 First Avenue, New York, NY, 10016, USA.
  • Marshall GT; Department of Surgery, Bellevue Hospital Center, New York University School of Medicine, 462 First Avenue, New York, NY, 10016, USA.
Eur J Trauma Emerg Surg ; 47(1): 145-151, 2021 Feb.
Article en En | MEDLINE | ID: mdl-31471669
BACKGROUND: Venous thromboembolism (VTE) is a common morbidity in trauma patients. Standard VTE chemoprophylaxis is often inadequate. We hypothesized that weight-based dosing would result in appropriate prophylaxis more reliably than fixed dosing. METHODS: All patients admitted to a Level 1 trauma center over a 6-month period were included unless contra-indications for VTE prophylaxis existed. A prospective adjusted-dosing group was compared to a retrospective uniform-dosing group. The adjusted-dosing approach consisted of initial weight-based dosing of 0.5 mg/kg subcutaneously (subQ) every 12 h (q12h). Peak anti-factor Xa was measured. Patients outside of the prophylactic range had their dose adjusted by ± 10 mg. The uniform-dosing group received 30 mg subQ q12h, without adjustments. RESULTS: Eighty-four patients were included: 44 in the retrospective control cohort and 40 in the prospective experimental cohort. More patients were sub-prophylactically dosed in the uniform-dosing group relative to the adjusted-dosing group (25% vs 5%, p = 0.03). There was no difference in overall prophylactic range targeting, because the supra-prophylactically dosed patients in the adjusted-dosing group eliminated the effect (p = 0.173). However, after a single dose adjustment, zero patients were outside of prophylactic range (25% versus 0%, RR = infinite, p = 0.003). In the uniform-dosing group, anti-Xa level correlated with body surface area (BSA; R2 = 0.33, p < 0.0001) and weight (R2 = 0.26, p = 0.0005). Weight-based dosing both pre- and post-readjustment normalized the correlation of anti-Xa with BSA (R2 = 0.07, p = 0.1) and weight (R2 = 0.07, p = 0.1). CONCLUSIONS: Weight-based VTE prophylaxis with anti-Xa-based dose adjustment improves prophylactic range targeting relative to uniform dosing and eliminates variances secondary to BSA and weight in trauma patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Peso Corporal / Enoxaparina / Tromboembolia Venosa / Inhibidores del Factor Xa / Anticoagulantes Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Trauma Emerg Surg Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Peso Corporal / Enoxaparina / Tromboembolia Venosa / Inhibidores del Factor Xa / Anticoagulantes Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Trauma Emerg Surg Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania